Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges (2019 - 2024)
Fennec Pharmaceuticals (FENC) posted Amortization of Deferred Charges of $4000.0 for Q1 2024, down 92.73% on a QoQ basis from $55000.0 in Q4 2023, and down 80.0% year-over-year from $20000.0 in Q2 2023.
Fennec Pharmaceuticals (FENC) Amortization of Deferred Charges (2019 - 2024) Analysis & Trends
Fennec Pharmaceuticals' Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $4000.0 for Q1 2024.
- Quarterly Amortization of Deferred Charges fell 80.0% year-over-year to $4000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $205000.0 (up 40.41% YoY) and the FY2024 annual result came in at $21000.0, down 90.5% from the prior year.
- Amortization of Deferred Charges was $4000.0 for Q1 2024 at Fennec Pharmaceuticals, down from $55000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $355000.0 in Q3 2020 and bottomed at $4000.0 in Q1 2024.
- A 5-year average of $55285.7 and a median of $25000.0 in 2020 frame the typical range for Amortization of Deferred Charges.
- Annual changes were most pronounced in 2020 — Amortization of Deferred Charges jumped 1988.24% — and 2021, when it plunged 97.75%.
- Fennec Pharmaceuticals' Amortization of Deferred Charges stood at $355000.0 in 2020, then slumped by 98.03% to $7000.0 in 2021, then soared by 685.71% to $55000.0 in 2022, then changed by 0.0% to $55000.0 in 2023, then slumped by 92.73% to $4000.0 in 2024.
- Business Quant data shows FENC's Amortization of Deferred Charges at $4000.0 in Q1 2024, $55000.0 in Q4 2023, and $53000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 55,000.00 |
| Dec 31, 2023 | 55,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Sep 30, 2023 | 53,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Jun 30, 2023 | 93,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Mar 31, 2022 | 6,000.00 |
| Dec 31, 2021 | 7,000.00 |
| Dec 31, 2021 | 7,000.00 |